Categoría: Press Releases

Nexo Therapeutics launched with $60 million in Series A funding led by Versant Ventures and outlined a platform designed to discover covalent drugs against previously intractable cancer targets. […]

Leer más… from Nexo Therapeutics Launches With $60 Million Series A Financing

MD Anderson and Nexo Therapeutics announced a multi-year collaboration that combines Nexo’s discovery platform with MD Anderson’s TRACTION capabilities to move new small-molecule cancer therapies toward the clinic. […]

Leer más… from MD Anderson and Nexo Therapeutics announce strategic research collaboration to advance new therapies against intractable targets